Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy

Bibliography

• Zeidan YH, Jenkins RW, Korman JB, Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets 2008;9(8):653-61
   PubMed Web of Science ®Google Scholar
• Angelucci A, Gravina GL, Rucci N, Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice. Endocr Relat Cancer 2006;13(1):197-210
   PubMed Web of Science ®Google Scholar
• Canil CM, Tannock IF. Is there a role for chemotherapy in prostate cancer? Br J Cancer 2004;91(6):1005-11
   PubMed Web of Science ®Google Scholar
• Ward JF, Slezak JM, Blute ML, Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005;95(6):751-6
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Fuks Z, Hunt M, High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166(3):876-81
   PubMed Web of Science ®Google Scholar
• Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 2003;4(4):233-41
   PubMed Web of Science ®Google Scholar
• Scardino PT. Early detection of prostate cancer. Urol Clin North Am 1989;16(4):635-55
   PubMed Web of Science ®Google Scholar
• Seidman H, Mushinski MH, Gelb SK, Silverberg E. Probabilities of eventually developing or dying of cancer–United States, 1985. Ca Cancer J Clin 1985;35(1):36-56
   PubMed Web of Science ®Google Scholar
• Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004;4(8):604-16
   PubMed Web of Science ®Google Scholar
• Futerman AH, Hannun YA. The complex life of simple sphingolipids. EMBO Rep 2004;5(8):777-82
   PubMed Web of Science ®Google Scholar
• Kim WJ, Okimoto RA, Purton LE, Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 2008;111(9):4716-22
   PubMed Web of Science ®Google Scholar
• Norris JS, Bielawska A, Day T, Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Ther 2006;13(12):1045-51
   PubMed Web of Science ®Google Scholar
• Ruckhaberle E, Rody A, Engels K, Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 2008;112(1):41-52
   PubMed Web of Science ®Google Scholar
• Senkal CE, Ponnusamy S, Rossi MJ, Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther 2007;6(2):712-22
   PubMed Web of Science ®Google Scholar
• Tilly JL, Kolesnick RN. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochimica et Biophysica Acta (BBA) - Mol Cell Biol Lipids 2002;1585(2-3):135-8
   PubMed Web of Science ®Google Scholar
• Wang X-Z, Beebe JR, Pwiti L, Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res 1999;59(22):5842-8
   PubMed Web of Science ®Google Scholar
• Mahdy AEM, Cheng JC, Li J, Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer. Mol Ther 2008;17(3):430-8
   PubMed Web of Science ®Google Scholar
• Pchejetski D, Doumerc N, Golzio M, Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther 2008;7(7):1836-45
   PubMed Web of Science ®Google Scholar
• Liu Y-Y, Han T-Y, Giuliano AE, Cabot MC. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 1999;274(2):1140-6
   PubMed Web of Science ®Google Scholar
• Gouaze V, Yu JY, Bleicher RJ, . Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther 2004;3(5):633-9
   PubMed Web of Science ®Google Scholar
• van Vlerken LE, Duan Z, Seiden MV, Amiji MM. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 2007;67(10):4843-50
   PubMed Web of Science ®Google Scholar
• Veldman RJ, Klappe K, Hinrichs J, Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. FASEB J 2002;16(9):1111-3
   PubMedGoogle Scholar
• Pchejetski D, Golzio M, Bonhoure E, Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 2005;65(24):11667-75
   PubMed Web of Science ®Google Scholar
• Garzotto M, Haimovitz-Friedman A, Liao W-C, Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. Cancer Res 1999;59(20):5194-201
   PubMed Web of Science ®Google Scholar
• Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4(5):397-407
   PubMed Web of Science ®Google Scholar
• Spiegel S, Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 2007;282(4):2125-9
   PubMed Web of Science ®Google Scholar
• Bonnaud S, Niaudet C, Pottier G, Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res 2007;67(4):1803-11
   PubMed Web of Science ®Google Scholar
• Chmura SJ, Nodzenski E, Kharbanda S, Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis. Mol Pharmacol 2000;57(4):792-6
   PubMed Web of Science ®Google Scholar
• Santana P, Pena LA, Haimovitz-Friedman A, Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996;86(2):189-99
   PubMed Web of Science ®Google Scholar
• Litvak DA, Bilchik AJ, Cabot MC. Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy. J Gastrointest Surg 2003;7(1):140-8; discussion 8
   PubMed Web of Science ®Google Scholar
• Alphonse G, Bionda C, Aloy MT, Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels. Oncogene 2004;23(15):2703-15
   PubMed Web of Science ®Google Scholar
• Samsel L, Zaidel G, Drumgoole HM, The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate 2004;58(4):382-93
   PubMed Web of Science ®Google Scholar
• Chalfant CE, Rathman K, Pinkerman RL, De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 2002;277(15):12587-95
   PubMed Web of Science ®Google Scholar
• Dobrowsky RT, Hannun YA. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 1992;267(8):5048-51
   PubMed Web of Science ®Google Scholar
• Chalfant CE, Kishikawa K, Mumby MC, Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem 1999;274(29):20313-7
   PubMed Web of Science ®Google Scholar
• Xin M, Deng X. Protein phosphatase 2A enhances the proapoptotic function of bax through dephosphorylation. J Biol Chem 2006;281(27):18859-67
   PubMed Web of Science ®Google Scholar
• Lin SS, Bassik MC, Suh H, PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum. J Biol Chem 2006;281(32):23003-12
   PubMed Web of Science ®Google Scholar
• Pastorino JG, Tafani M, Rothman RJ, Functional consequences of the sustained or transient activation by bax of the mitochondrial permeability transition pore. J Biol Chem 1999;274(44):31734-9
   PubMed Web of Science ®Google Scholar
• Verheij M, van Blitterswijk WJ, Bartelink H. Radiation-induced apoptosis–the ceramide-SAPK signaling pathway and clinical aspects. Acta Oncol 1998;37(6):575-81
   PubMed Web of Science ®Google Scholar
• Gulbins E. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 2003;47(5):393-9
   PubMed Web of Science ®Google Scholar
• Verheij M, Bose R, Lin XH, Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996;380(6569):75-9
   PubMed Web of Science ®Google Scholar
• Yao B, Zhang Y, Delikat S, Phosphorylation of raf by ceramide-activated protein kinase. Nature 1995;378(6554):307-10
   PubMed Web of Science ®Google Scholar
• Kashiwagi K, Shirai Y, Kuriyama M, Importance of C1B domain for lipid messenger-induced targeting of protein kinase C. J Biol Chem 2002;277(20):18037-45
   PubMed Web of Science ®Google Scholar
• Deiss LP, Galinka H, Berissi H, Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996;15(15):3861-70
   PubMed Web of Science ®Google Scholar
• Pattingre S, Bauvy C, Carpentier S, Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J Biol Chem 2009;284(5):2719-28
   PubMed Web of Science ®Google Scholar
• Daido S, Kanzawa T, Yamamoto A, Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 2004;64(12):4286-93
   PubMed Web of Science ®Google Scholar
• Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 2004;206(2):169-80
   PubMed Web of Science ®Google Scholar
• Hannun YA, Luberto C, Argraves KM. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 2001;40(16):4893-903
   PubMed Web of Science ®Google Scholar
• Koch J, Gartner S, Li CM, Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing farber disease. J Biol Chem 1996;271(51):33110-5
   PubMed Web of Science ®Google Scholar
• Mao C, Xu R, Szulc ZM, Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J of Biol Chem 2001;276(28):26577-88
   PubMed Web of Science ®Google Scholar
• El Bawab S, Cungui M, Obeid LM, Hannun YA. Ceramidases in the regulation of ceramide levels and function. In: Quinn PJ, Kagan VE, editors, Subcellular biochemistry: phospholipid metabolism in apoptosis. New York: Kluwer Academic/Plenum Publishers; 2002. p. 187-205
   Google Scholar
• Mao C, Obeid LM. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta (BBA) Mol Cell Biol Lipids 2008;1781(9):424-34
   PubMed Web of Science ®Google Scholar
• Li CM, Park JH, He XX, The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 1999;62(2):223-31
   PubMed Web of Science ®Google Scholar
• Park J-H, Schuchman EH. Acid ceramidase and human disease. Biochim Biophys Acta (BBA) Biomembr 2006;1758(12):2133-8
   PubMed Web of Science ®Google Scholar
• Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation [comment]. Science 1989;243(4890):500-7
   PubMed Web of Science ®Google Scholar
• Spiegel S, Cuvillier O, Edsall LC, Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci 1998;845:11-8
   PubMed Web of Science ®Google Scholar
• Spiegel S, Merrill AH. Sphingolipid metabolism and cell growth regulation. FASEB J 1996;10(12):1388-97
   PubMed Web of Science ®Google Scholar
• Seelan RS, Qian C, Yokomizo A, Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer 2000;29(2):137-46
   PubMed Web of Science ®Google Scholar
• Narla G, Heath KE, Reeves HL, KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001;294(5551):2563-6
   PubMed Web of Science ®Google Scholar
• Chen C, Hyytinen E-R, Sun X, Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 2003;162(4):1349-54
   PubMed Web of Science ®Google Scholar
• Ito G, Uchiyama M, Kondo M, Kruppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 2004;64(11):3838-43
   PubMed Web of Science ®Google Scholar
• Kremer-Tal S, Reeves HL, Narla G, Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 2004;40(5):1047-52
   PubMed Web of Science ®Google Scholar
• Reeves HL, Narla G, Ogunbiyi O, Kruppel-Like Factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gasteroenterology 2004;126:1090-103
   PubMed Web of Science ®Google Scholar
• Wang S, Chen S, Zhang W, Qiu F. KLF6mRNA expression in primary hepatocellular carcinoma. J Huazhong Univ Sci Technolog Med Sci 2004;24:585-7
   PubMedGoogle Scholar
• Yung-Ming Jeng H-CH. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 2003;105(5):625-9
   PubMed Web of Science ®Google Scholar
• Narla G, DiFeo A, Yao S, Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res 2005;65(13):5761-8
   PubMed Web of Science ®Google Scholar
• Seppala EH, Autio V, Duggal P, KLF6 IVS1 -27G>A variant and the risk of prostate cancer in Finland. Eur Urol 2007;52(4):1076-81
   PubMed Web of Science ®Google Scholar
• Park J-H, Eliyahu E, Narla G, KLF6 is one transcription factor involved in regulating acid ceramidase gene expression. Biochim Biophys Acta (BBA) Gene Struct Expr 2005;1732(1-3):82-7
   PubMedGoogle Scholar
• Lucki N, Sewer MB. The cAMP responsive element binding protein (CREB) regulates the expression of acid ceramidase (ASAH1) in H295R human adrenocortical cells. Biochim Biophys Acta 2009;1791(8):706-13
   Google Scholar
• Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001;20(3-4):173-93
   PubMed Web of Science ®Google Scholar
• Gandellini P, Folini M, Zaffaroni N. Towards the definition of prostate cancer-related microRNAs: where are we now? Trends Mol Med 2009;15(9):381-90
   PubMed Web of Science ®Google Scholar
• Saad AF, Meacham WD, Bai A, The functional effects of acid ceramidase over-expression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther 2007;6(9):1455-60
   PubMed Web of Science ®Google Scholar
• Bedia C, Canals D, Matabosch X, Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides. Chem Physics Lipids 2008;156(1-2):33-40
   PubMed Web of Science ®Google Scholar
• Karahatay S, Thomas K, Koybasi S, Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett 2007;256(1):101-11
   PubMed Web of Science ®Google Scholar
• Bielawska A, Bielawski J, Szulc ZM, Novel analogs of D-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipids. Bioorg Med Chem 2008;16(2):1032-45
   PubMed Web of Science ®Google Scholar
• Szulc ZM, Mayroo N, Bai A, Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents. Bioorg Med Chem 2008;16(2):1015-31
   PubMed Web of Science ®Google Scholar
• Maceyka M, Alvarez SE, Milstien S, Spiegel S. Filamin A links sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 at lamellipodia to orchestrate cell migration. Mol Cell Biol 2008;28(18):5687-97
   PubMed Web of Science ®Google Scholar
• Shah MV, Zhang R, Irby R, Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 2008;112(3):770-81
   PubMed Web of Science ®Google Scholar
• Musumarra G, Barresi V, Condorelli DF, Scirè S. A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics. Biol Chem 2003;384(2):321-7
   PubMed Web of Science ®Google Scholar
• Elojeimy S, Liu X, McKillop JC, Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy. Mol Ther 2007;15(7):1259-63
   PubMed Web of Science ®Google Scholar
• Holman D, Turner L, El-Zawahry A, Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemother Pharmacol 2008;61(2):231-42
   PubMed Web of Science ®Google Scholar
• Eto M, Bennouna J, Hunter OC, C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells. Prostate 2003;57(1):66-79
   PubMed Web of Science ®Google Scholar
• Eto M, Bennouna J, Hunter OC, Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells. Int J Urol 2006 02;13(2):148-56
   PubMed Web of Science ®Google Scholar
• Strelow A, Bernardo K, Adam-Klages S, Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J Exp Med 2000;192(5):601-12
   PubMed Web of Science ®Google Scholar
• Morales A, Paris R, Villanueva A, Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene 2006;26(6):905-16
   PubMed Web of Science ®Google Scholar
• Tannock IF, de Wit R, Berry WR, Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351(15):1502-12
   PubMed Web of Science ®Google Scholar
• Petrylak DP, Tangen CM, Hussain MH, Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004;351(15):1513-20
   PubMed Web of Science ®Google Scholar
• Kumar P, Perrotti M, Weiss R, Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate. J Clin Oncol 2004;22(10):1909-15
   PubMed Web of Science ®Google Scholar
• Sanfilippo NJ, Taneja SS, Chachoua A, Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer. J Clin Oncol 2008;26(18):2973-8
   PubMed Web of Science ®Google Scholar
• Sui M, Dziadyk JM, Zhu X, Fan W. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy. Clin Cancer Res 2004;10(14):4848-57
   PubMed Web of Science ®Google Scholar
• Liebmann J, Cook JA, Fisher J, Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (taxol). Int J Radiat Oncol Biol Phys 1994;29(3):559-64
   PubMed Web of Science ®Google Scholar
• Ingram ML. Redpath JL Subadditive interaction of radiation taxol in vitro. Int J Radiat Oncol Biol Phys 1997;37(5):1139-44
   PubMed Web of Science ®Google Scholar
• Stromberg JS, Lee YJ, Armour EP, Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer 1995;75(9):2262-8
   PubMed Web of Science ®Google Scholar
• Geard CR, Jones JM. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 1994;29(3):565-9
   PubMed Web of Science ®Google Scholar
• Mehta S, Blackinton D, Omar I, Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother Pharmacol 2000;46(2):85-92
   PubMed Web of Science ®Google Scholar
• Selzner M, Bielawska A, Morse MA, Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 2001;61(3):1233-40
   PubMed Web of Science ®Google Scholar
• Saddoughi SA, Song P, Ogretmen B Roles of bioactive sphingolipids in cancer biology therapeutics. Subcell. Biochem 2008;49:413-40
   Google Scholar
• Senchenkov A, Litvak DA, Cabot MC. Targeting ceramide metabolism–a strategy for overcoming drug resistance. J Natl Cancer Inst 2001;93(5):347-57
   PubMedGoogle Scholar
• Raisova M, Goltz G, Bektas M, Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett 2002;516(1-3):47-52
   PubMed Web of Science ®Google Scholar
• Bai A, Szulc ZM, Bielawski J, Synthesis and bioevaluation of ω-N-amino analogs of B13. Bioorg Med Chem 2009;17(5):1840-8
   PubMed Web of Science ®Google Scholar